2017 Q2 Form 10-Q Financial Statement

#000114420417024692 Filed on May 05, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q1
Revenue $0.00 $0.00 $8.800K
YoY Change -100.0%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $8.800K
YoY Change -100.0%
Gross Profit Margin 100.0%
Selling, General & Admin $156.2K $122.7K $0.00
YoY Change
% of Gross Profit 0.0%
Research & Development $100.0K $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $364.00 $72.00
YoY Change
% of Gross Profit
Operating Expenses $156.2K $58.79K $20.91K
YoY Change 181.21%
Operating Profit -$156.2K -$122.7K -$12.11K
YoY Change 913.98%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $247.00 $0.00
YoY Change
Pretax Income -$156.0K -$122.7K -$12.11K
YoY Change 913.98%
Income Tax -$7.049K -$12.35K $0.00
% Of Pretax Income
Net Earnings -$149.0K -$110.4K -$12.11K
YoY Change 811.92%
Net Earnings / Revenue -137.56%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 51.50M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $14.66K $56.19K $1.019K
Short-Term Investments
Other Short-Term Assets $64.12K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $101.0K $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $8.232K
YoY Change
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $28.07K $76.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $101.0K $0.00 $0.00
Total Long-Term Assets $28.07K $76.00 $0.00
Total Assets $100.0K $76.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $95.02K $26.77K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $435.8K $100.0K $0.00
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $435.8K $100.0K $0.00
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $400.0K $54.45K $0.00
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$70.32K
YoY Change
Common Stock $7.500K $5.149K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$306.7K -$54.37K $0.00
YoY Change
Total Liabilities & Shareholders Equity $100.0K $76.00 $0.00
YoY Change

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$149.0K -$110.4K -$12.11K
YoY Change 811.92%
Depreciation, Depletion And Amortization $364.00 $72.00
YoY Change
Cash From Operating Activities -$100.0K -$8.451K -$12.11K
YoY Change -30.19%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $4.083K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$4.083K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 100.0K $66.97K $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -100.0K -$8.451K -$12.11K
Cash From Investing Activities 0.000 -$4.083K 0.000
Cash From Financing Activities 100.0K $66.97K $0.00
Net Change In Cash 0.000 $54.44K -$12.11K
YoY Change -549.71%
FREE CASH FLOW
Cash From Operating Activities -$100.0K -$8.451K -$12.11K
Capital Expenditures $0.00 $4.083K $0.00
Free Cash Flow -$100.0K -$12.53K -$12.11K
YoY Change 3.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76 USD
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26767 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 USD
CY2017Q1 us-gaap Liabilities
Liabilities
54447 USD
CY2016Q4 us-gaap Liabilities
Liabilities
0 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
5149 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
5149 USD
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10801 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10801 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70321 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15536 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
414 USD
CY2017Q1 us-gaap Revenues
Revenues
64002 USD
CY2016Q1 us-gaap Revenues
Revenues
8800 USD
CY2017Q1 us-gaap Legal Fees
LegalFees
14616 USD
CY2016Q1 us-gaap Legal Fees
LegalFees
500 USD
CY2017Q1 us-gaap Professional Fees
ProfessionalFees
5000 USD
CY2016Q1 us-gaap Professional Fees
ProfessionalFees
1000 USD
CY2017Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
421 USD
CY2016Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
65 USD
CY2017Q1 us-gaap Noninterest Expense Distribution And Servicing Fees
NoninterestExpenseDistributionAndServicingFees
21730 USD
CY2016Q1 us-gaap Noninterest Expense Distribution And Servicing Fees
NoninterestExpenseDistributionAndServicingFees
500 USD
CY2017Q1 us-gaap Clearance Fees
ClearanceFees
140 USD
CY2016Q1 us-gaap Clearance Fees
ClearanceFees
65 USD
CY2017Q1 us-gaap Other General Expense
OtherGeneralExpense
6880 USD
CY2016Q1 us-gaap Other General Expense
OtherGeneralExpense
775 USD
CY2017Q1 iwbb Overthecounter Market Cost
OverthecounterMarketCost
10000 USD
CY2016Q1 iwbb Overthecounter Market Cost
OverthecounterMarketCost
12500 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
58787 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
20905 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-54785 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-12105 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-54785 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-12105 USD
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
414 USD
CY2017Q1 us-gaap Assets
Assets
76 USD
CY2016Q4 us-gaap Assets
Assets
414 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-54371 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
414 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
26767 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51495000 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51495000 shares
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27680 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-338 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12105 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13124 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1019 USD
CY2017Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28018 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12105 USD
CY2017Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
IWEB, Inc.
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001648365
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Trading Symbol
TradingSymbol
IWBB
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51495000 shares
CY2017Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b>NOTE 1 &#150; DESCRIPTION OF BUSINESS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">IWEB, Inc. (the &#8220;Company&#8221;) was incorporated under the laws of the State of Nevada on February 17, 2015. The primary operations of the business will be to actively engage in providing high impact internet marketing strategies to internet based businesses and people seeking to create websites. These services will seek to place customers&#8217; websites in search engine rankings for selected keywords that describe the products or services offered by such customers. This is a highly technical strategy that involves the use of algorithms for relevant content. We provide customers with the web application development services for many different computing needs. The focus of these services is the development of Web sites technology using different types of templates such as: HTML, Word Press, Web templates, Joomla. On December 12, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 49,995,000</font> shares of the common stock of the Company, representing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 97.08</font>% of the Company&#8217;s issued and outstanding shares of common stock at that time, were sold by Dmitriy Kolyvayko in a private transaction to Mr. Wai Hok Fung (the &#8220;Transaction&#8221;) for an aggregate purchase price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">380,000</font>.&#160; <font style="BACKGROUND: transparent">In connection with the Transaction, Mr. Kolyvayko released the Company from certain liabilities and obligations arising out of his service as a director and officer of the Company.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">As a start&#150;up company, the Company had limited operating revenues through March 31, 2017. The revenue was generated from clients&#8217; payments. The Company is currently devoting substantially all of its present time to the performance of work for, and development of a potential joint project with Unusual Concepts, which is currently our only customer.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">On January 5, 2017, the Company&#8217;s Board of Directors approved an amendment to the Company&#8217;s Bylaws to change the Company&#8217;s fiscal year end from June 30 to December 31, effective as of December 31, 2016.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b>Use of estimates</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b>Cost</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify">Amounts that are recorded as cost of services relate to expenses incurred for the Company&#8217;s service processes. Such costs are recorded and allocated as incurred. The Company&#8217;s service costs consist primarily of expenses related to the development and implementation of its services, such as consulting time that it spends or anticipates spending on a project.&#160;</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
18627 USD
CY2016Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
4116 USD
CY2016Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-4116 USD
CY2017Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-18627 USD
CY2017Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23909 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5282 USD
CY2017Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23909 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5282 USD
CY2017Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2017Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
27680 USD
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51495000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51495000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51495000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51495000 shares
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
60000 USD
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
4002 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
8800 USD
CY2017Q1 iwbb Iwebdtcsolutions
Iwebdtcsolutions
0 USD
CY2016Q1 iwbb Iwebdtcsolutions
Iwebdtcsolutions
5500 USD
CY2017Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
27680 USD
CY2016Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2017Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2017Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
70321 USD
CY2017Q1 iwbb Operating Loss Carryforwards Expiration Period
OperatingLossCarryforwardsExpirationPeriod
The tax losses begin to expire in 2035

Files In Submission

Name View Source Status
0001144204-17-024692-index-headers.html Edgar Link pending
0001144204-17-024692-index.html Edgar Link pending
0001144204-17-024692.txt Edgar Link pending
0001144204-17-024692-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iwbb-20170331.xml Edgar Link completed
iwbb-20170331.xsd Edgar Link pending
iwbb-20170331_cal.xml Edgar Link unprocessable
iwbb-20170331_def.xml Edgar Link unprocessable
iwbb-20170331_lab.xml Edgar Link unprocessable
iwbb-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v465965_10q.htm Edgar Link pending
v465965_ex31-1.htm Edgar Link pending
v465965_ex31-2.htm Edgar Link pending
v465965_ex32-1.htm Edgar Link pending